An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
Glioblastoma is a deadly disease and even aggressive neurosurgical resection followed by radiation and chemotherapy only extends patient survival to a median of 1.5 years. The challenge in treating this type of tumor stems from the rapid proliferation of the malignant glioma cells, the diffuse infil...
Main Authors: | Wong, Eric T, Lok, Edwin, Swanson, Kenneth D. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer US
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491358/ |
Similar Items
-
An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
by: Swanson, Kenneth D., et al.
Published: (2016) -
Computed modeling of alternating electric fields therapy for recurrent glioblastoma
by: Lok, Edwin, et al.
Published: (2015) -
Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation
by: Wong, Eric T, et al.
Published: (2015) -
Gene therapy for malignant glioma
by: Okura, Hidehiro, et al.
Published: (2014) -
Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid
by: Lok, Edwin, et al.
Published: (2014)